UNSPSC 85681502: Revision of nonautologous tissue substitute in facial bone, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in facial bone, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NWW3KZ

UNSPSC 85681502 Revision of nonautologous tissue substitute in facial bone, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its medical procedure description. The six recent opportunities posted under this code between July and September 2026—spanning independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—are administrative healthcare contracting, benefits program management, and occupational health services rather than orthopedic or reconstructive surgical procedures. None of the opportunities involves facial bone reconstruction, tissue grafting, or the procedural infrastructure the code nominates.

The mismatch between the code's nominal scope and actual recent opportunities suggests either a state and local procurement tagging error or that this specific surgical procedure line is not actively procured through state and local channels at present. Jurisdictions posting opportunities under this code include the City of Phoenix, City of Long Beach, Washington State Department of Transportation (ferries division), Harris County Juvenile Probation Department, Collier County (Florida), and Santa Clara County Health System, spanning Arizona, California, Florida, and Washington. However, because none of these opportunities substantively address facial bone revision or nonautologous tissue substitution, the code does not present actionable procurement signals for vendors in reconstructive or orthopedic surgery supply, surgical services, or related medical device distribution.